The thick client is making a comeback. Here’s how next-generation local databases like PGlite and RxDB are bringing ...

Construction is scheduled to commence in spring 2026, with both facilities anticipated to be fully operational by 2029.

AbbVie invests $380 million to build two new API manufacturing facilities in North Chicago while Bora Pharmaceuticals Co., Ltd. and GSK have renewed a five-year global manufacturing partnership.

AbbVie invests $380m in North Chicago for API manufacturing, creating 300 jobs, boosting US R&D, and expanding domestic ...

Feb 23 (Reuters) - AbbVie on Monday said it would invest $380 million to build two new active pharmaceutical ingredient ...

The Chicago-based biopharmaceutical company AbbVie made a significant move on Feb. 23, as part of its broader commitment to ...

ByteDance's viral video generation model Seedance 2.0 was closely integrated with the Spring Festival gala's programming on Monday night China's "big tech" giants - including Alibaba Group Holding, ...

Drilling permits issued by the Texas Railroad Commission, the state's oil and gas industry regulator.

AbbVie is investing $380 million to build two new active pharmaceutical ingredient manufacturing facilities at its headquarters campus in North Chicago. Construction is set to begin in spring 2026, ...

The active pharmaceutical ingredient manufacturing facilities are part of a broader $100 billion investment commitment to strengthen the company’s U.S. manufacturing capabilities.

Just like algae blooms in the ocean and pollen in the spring, there’s been an explosion in the past year or two of new software, related tools and lingo from the IT and mainstream/consumer side. Some ...